20 artigos
New research reveals how chronic inflammation varies by person, paving the way for personalized interventions to combat age-related diseases.
Descubra como a inflamação crônica de baixo grau impulsiona o processo de envelhecimento e aprenda estratégias para combater essa ameaça silenciosa à longevidade.
A comprehensive review reveals how inflammaging—the fusion of aging and inflammation—fuels cardiovascular disease through senescence, mitochondrial dysfunction, and gut dysbiosis.
Domine a arquitetura molecular da disregulação do complemento no envelhecimento — da bioquímica das proteínas regulatórias aos alvos terapêuticos de ponta — e entenda como intervenções de precisão podem restaurar o equilíbrio sem desmantelar a imunidade.
New research reveals how low-grade inflammation creates a cycle of liver damage in older adults, pointing to promising therapeutic targets.
Vá além do básico para explorar como as vias do complemento, as falhas regulatórias e as células senescentes interagem para impulsionar a inflamação crônica que acelera o envelhecimento em nível molecular.
A major cross-population study finds that chronic inflammation linked to aging may reflect industrialized lifestyles, not biology alone.
BioAge's oral NLRP3 inhibitor BGE-102 cut hsCRP by ~85% in weeks, signaling a potential breakthrough in treating chronic inflammation at scale.
Uma análise mecanicista aprofundada das intervenções de ponta contra o inflamaging — da farmacologia senolítica e do direcionamento preciso de citocinas às estratégias de reprogramação parcial que visam restaurar a homeostase imunológica juvenil.
New therapies targeting inflammation pathways could reduce cardiovascular disease and slow kidney disease progression in CKD patients.
Belgian biotech Coultreon raises $125M to advance an oral SIK3 inhibitor that rebalances inflammation rather than suppressing immunity outright.
New research links chronic low-grade inflammation to faster epigenetic aging, measured across four validated biological clocks.
New research reveals how fat-derived molecules naturally shut down inflammation, offering hope for safer arthritis and heart disease treatments.
BioAge's oral drug BGE-102 dramatically reduced hsCRP and IL-6 in obese participants with elevated inflammation, with a strong safety profile.
Senescent T cells fuel psoriasis, eczema, and rosacea through toxic secretions. New therapies may finally break the cycle.
Mendelian randomization links circulating inflammatory proteins to retinal microvascular changes, heart disease risk, and lifespan — establishing causal direction.
A landmark 2025 review maps the molecular and cellular mechanisms driving immune aging, linking inflammaging to cancer, neurodegeneration, and infection.
Revolutionary framework combines quarterly biomarker testing with AI-powered lifestyle coaching to reduce aging-related inflammation.
New research maps the connection between cellular senescence, chronic inflammation, and cardiovascular disease progression.
Vá além do básico do inflammaging para entender como o envelhecimento remodela as populações de células imunes, desencadeia o SASP e mantém o organismo em um estado de inflamação crônica de baixo grau no nível molecular.
